News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Omnicom Group Inc. held its Q4 2025 earnings call, discussing its acquisition of Interpublic and the resulting creation of the world's leading marketing and sales company. The company announced a $5 billion share repurchase program and expects to achieve $1.5 billion in annual run-rate …
Sharemaestro market context Price above Trend Line 52 weeks +8.6% · Next-week setup negative 39.5%AM Best has reaffirmed its A (Excellent) financial strength rating for Global Indemnity Group, LLC's U.S. insurance subsidiaries for the 24th consecutive year. This rating signifies the company's robust financial health, conservative investment practices, and consistent profitability in its specialty insurance sector. The affirmation …
1 Healthcare Stock Worth Your Attention and 2 We Ignore From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.3% over …
Zacks Research has lowered its FY2026 EPS forecast for Global Indemnity Group (NASDAQ:GBLI) to $2.37, falling short of the $2.68 consensus estimate, and projected FY2027 EPS at $2.96. This follows Global Indemnity reporting quarterly EPS of $0.59, missing analysts’ consensus of $0.63, despite revenues …
Dimensional Fund Advisors LP has reduced its stake in AMN Healthcare Services Inc. by 5.7%, selling 44,529 shares and retaining 741,209 shares valued at approximately $13.6 million. This comes after AMN Healthcare reported a strong second quarter with adjusted EPS of $0.77 and revenue …
Omnicell, Inc. reported strong Q2 2026 results with increased revenue and net income, alongside upgraded guidance for the full year 2026. This improved profitability and higher revenue outlook strengthen the company's investment narrative, which relies on medication management automation and a growing software and …
AMN Healthcare Services' stock has seen a significant rally in 2026, making its valuation mixed with some indicators showing undervaluation and others suggesting it's overvalued. A Discounted Cash Flow (DCF) analysis indicates the stock could be 12.9% undervalued, supported by strong Q2 2026 earnings, …
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. AMN Healthcare Services (AMN) drew fresh attention after reporting second quarter 2026 earnings, with positive net income and earnings per share from continuing operations, alongside …
OmniAb (NASDAQ:OABI) reported its quarterly earnings, beating analyst expectations with an adjusted loss of $0.05 per share against an estimated $0.12 loss, and revenues of $13.41 million significantly surpassing estimates of $4.69 million. The company's Q2 revenue increased year-over-year, and its net loss narrowed, …
AMN Healthcare Services (AMN) recently reported a rebound to profit in its Q2 2026 results, alongside increased sales and new revenue guidance. Despite strong year-to-date and one-year share price returns, the stock has seen short-term pressure. The article explores whether the recent earnings rebound …
AMN Healthcare Services Inc's average 12-month price target has been increased to $34.29 by 7 analysts, up from $33.29, with forecasts ranging from $26 to $40 per share. This new target suggests an 11% potential upside from the August 6 closing price. The consensus …
Omnicell (OMCL) reported strong Q2 2026 earnings, leading to a rebound in its stock price and updated full-year revenue guidance. The company is considered undervalued by Simply Wall St's narrative, with a fair value of $61.29 compared to its current price of $36.81, driven …
Omnicom Group Inc. (OMC) is showing strong near-term sentiment which could influence neutral mid and long-term outlooks, with a breakout underway suggesting higher levels. The article provides AI-generated trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for …
Analysts have given AMN Healthcare Services Inc (NYSE:AMN) an average "Hold" rating, with a 12-month price target below its current stock price. Despite a challenging staffing market, the company reported strong second-quarter results, significantly exceeding EPS and revenue expectations, driven by growth in travel …
Novo Nordisk has appointed Omnicom as its agency of record for U.S. media buying, ending its six-year partnership with WPP's Wavemaker. The agreement, valued at $520 million, will see Omnicom manage Novo's media buying in the U.S. starting in the fourth quarter. This move …
AMN Healthcare Services (NYSE:AMN) reached a new 52-week high of $36.86 after UBS Group raised its price target to $35.00, although maintaining a neutral rating. The company reported strong second-quarter results, significantly exceeding adjusted EPS and revenue expectations, and provided optimistic third-quarter revenue guidance. …
AMN Healthcare Services Inc. reported its second-quarter 2026 results, showing a return to profitability with net income of $21.2 million and diluted EPS of $0.53, an improvement from a loss in the prior-year quarter. Revenue increased to $673.2 million, driven by strong growth in …
OmniAb, Inc. (OABI) has released its Q2 2026 earnings call presentation. The company reported an EPS of -$0.05, which beat estimates by $0.08, and revenue of $13.42 million, exceeding expectations by $8.72 million and representing a 244.24% year-over-year increase. The slide deck provides details …
AMN Healthcare Services (NYSE:AMN) reported a significant beat in its Q2 2026 earnings, with adjusted diluted EPS of $0.77 against an estimated $0.19, reflecting a 305.3% beat. Revenue increased 2.0% year-over-year to $673.2M, driven by strong performance in the Nurse and Allied Solutions division. …
AMN Healthcare Services reported a significant increase in first-half 2026 revenue to $2.05 billion, a 52% rise year-over-year, primarily driven by labor disruption staffing in its nurse and allied solutions segment. The company returned to profitability with a net income of $83.3 million for …
This article provides an in-depth analysis of Omnicell's (OMCL) stock forecast and analyst predictions, highlighting expected earnings and revenue growth, key financial updates, and recent market activities. It covers various updates including earnings guidance, price target changes, leadership appointments, and new product launches like …
SOMNIGROUP INTERNATIONAL INC. (SGI) reported its 2026 quarterly results, showing a slight decrease in revenue to $1.82 billion, down 3% year-over-year. Despite the revenue dip, net income increased by 11.2% to $110.6 million, and diluted EPS rose by 10.6% to $0.52. The company highlighted …
OmniAb, Inc. (OABI) reported a significant increase in revenue for the first half of 2026, reaching $27.8 million, up from $3.9 million in the prior comparable period. This growth was primarily driven by license and milestone receipts. Despite remaining net loss-making, the diluted loss …
This article from TradingKey provides a stock news page for Omnicom Group Inc (OMC). It displays current stock performance with a 3.33% increase, market cap, and links to various financial data points. The page indicates that more news will be available soon.
MNTN, Inc. saw its stock price increase by 19% despite reporting quarterly earnings per share that missed analyst estimates by 51%, while revenue was in line with predictions. Following these results, analysts maintained their revenue forecasts but substantially lowered their EPS estimates for 2026, …
Royal Bank of Canada reduced its stake in Omnicell, Inc. by 12.9%, selling 78,803 shares but still retaining 532,172 shares valued at approximately $17.8 million. Other institutional investors have also adjusted their positions, and Omnicell reported strong quarterly earnings, beating analyst estimates with a …
First Trust Advisors LP significantly reduced its stake in Omnicell, Inc. during the first quarter, selling over 46,000 shares but still retaining a $2.85 million position. Despite this reduction, institutional investors collectively own a substantial 97.7% of OMCL. Analyst sentiment remains largely positive, with …
Amneal Pharmaceuticals (AMRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The Zacks …
Search by ticker symbol or company name and select a result to open its chart.